Trials / Terminated
TerminatedNCT02744482
Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis
Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis Double-blind Randomized Study Versus Placebo
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- University Hospital, Limoges · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an experimental study, prospective, comparative. This clinical trial is randomized and double-blind, Residronate versus placebo. The study aims to demonstrate the effectiveness of risedronate in pain management, after 18 month of traitment, in patients undergoing aseptic joint prosthesis loosening. 2 groups were compared with a 1: 1 ratio. The first group receives active drug (risedronate 75mg) and the second a placebo. Patients are treated during 18 months: 1 tablet residronate/placebo per os two consecutive days each month. Evaluations are planned evry 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | risedronate | risedrante tablet (75 mg) |
| DRUG | placebo | risedrante placebo tablet (75 mg) |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-03-22
- Completion
- 2018-03-22
- First posted
- 2016-04-20
- Last updated
- 2018-10-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02744482. Inclusion in this directory is not an endorsement.